Latest Healthcare Research Reports

Tag: Cell therapy Processing Market

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    Cell Therapy Processing Market Outlook 2026–2030 Exploring New Business Opportunities

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The Cell Therapy Processing Market During The Forecast Period 2026–2030?

    The cell therapy processing market has witnessed significant growth in recent years. It is projected to expand from $5.18 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to a confluence of factors, including the increasing number of clinical trials for cell therapies, the expansion of biopharmaceutical manufacturing capacity, the availability of specialized processing facilities, developing expertise in GMP compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is poised for substantial expansion over the next few years. Its valuation is expected to reach $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast period can be linked to the increasing commercialization of gene and cell therapies, a rising need for contract manufacturing services, the spread of decentralized manufacturing models, the increasing implementation of digital quality management systems, and a surge in regulatory approvals for cell-based treatments. Significant trends for the forecast period encompass a greater adoption of GMP-compliant processing platforms, an escalating demand for scalable cell therapy manufacturing, the growing incorporation of workflow automation software, further expansion of contract processing services, and an intensified focus on sterility and quality assurance.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Major Factors Are Driving The Expansion Of The Cell Therapy Processing Market?

    The increasing volume of cell therapy research endeavors is anticipated to fuel the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic agents from live cells to address or manage various conditions, such as cancers, autoimmune issues, and genetic ailments. The escalating need for cell-based treatments stems from a rising requirement for scalable and uniform manufacturing systems capable of handling high cell concentrations without sacrificing product integrity. Furthermore, cell therapy processing proves advantageous for cell therapy investigations because it facilitates the standardized creation, quality verification, and large-scale manufacturing of superior cells, thereby guaranteeing dependable and consistent results for both experimental and clinical analyses. As an illustration, data from December 2024, provided by the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, indicated that six first-in-class cell and gene treatments became available in 2023, representing 50% more than the three released in 2022. Consequently, the growing quantity of cell therapy research efforts is propelling the growth of the cell therapy processing market.

    What Market Segments Are Evaluated Within The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Trends Shaping The Direction Of The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system functions as a unified apparatus that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without requiring intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT) manufacturing, unveiled LimONE, an automated, closed-system platform for cell therapy production. This innovative system incorporates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, including incubation, centrifugation, and reagent handling, into one compact unit, thereby enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing without the necessity for intricate technology transfers.

    Who Are The Top Market Participants Influencing The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Read the full cell therapy processing market report here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Currently Holds The Largest Share Of The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Therapy Processing Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Cell Line Development Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-line-development-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Expansion Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Technological Innovations Such as Multi-Channel Asynchronous Processing Advancing the Cell Processing Instruments Market

    Technological Innovations Such as Multi-Channel Asynchronous Processing Advancing the Cell Processing Instruments Market

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Increase Is Anticipated For The Cell Processing Instruments Market Over The 2026–2030 Period?

    The cell processing instruments market has experienced substantial expansion in recent years. It is projected to expand from $6.95 billion in 2025 to $7.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. Historically, this growth was driven by factors such as a lack of automation in cell processing, the dependence on manual methods for cell counting and separation, increasing academic and research pursuits, a rising need for precise cell analysis, and the advent of flow cytometry technologies.

    The cell processing instruments market is anticipated to experience substantial expansion over the coming years. Its value is projected to reach $10.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period is attributable to several factors, including the emergence of integrated cell processing platforms, increased capital expenditure in cell therapy and regenerative medicine, the uptake of digital and automated imaging technologies, a surge in contract research and manufacturing endeavors, and innovations in live cell analysis and high-content screening. Key trends for the forecast period encompass a growing need for automated cell processing solutions, wider implementation of flow cytometry and high-content imaging, expansion in the applications of cell therapy and regenerative medicine, a heightened focus on standardization and adherence to regulations, and the incorporation of multi-functional cell analysis platforms.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Economic Or Industry Drivers Are Impacting The Cell Processing Instruments Market?

    The expansion of investment in biopharmaceutical research is projected to fuel the advancement of the cell processing instruments market in the future. Biopharmaceutical research encompasses the scientific investigation and creation of therapeutic items originating from biological sources or engineered to imitate biological molecules, used for diagnosing, preventing, or treating illnesses. The rise in biopharmaceutical research investment stems from an increasing need for novel treatments to tackle the growing prevalence of chronic diseases and fulfill outstanding medical requirements, thereby stimulating more extensive research and development initiatives for precise and efficacious remedies. Cell processing instruments facilitate biopharmaceutical research by allowing for effective, standardized, and scalable manipulation of cells, which in turn hastens the creation and manufacturing of sophisticated cell-based therapies. For instance, in January 2025, as reported by the BioIndustry Association (BIA), a trade association based in the UK, the UK biotech sector observed significant expansion in 2024, attracting £3.5 billion (around $ 4.4 billion) in investment, which marks an impressive 94% increase compared to the prior year. Consequently, the escalating investment within biopharmaceutical research is propelling the growth of the cell processing instruments market.

    How Is The Cell Processing Instruments Market Segmented Across Key Categories?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Upcoming Trends Are Expected To Influence The Cell Processing Instruments Market?

    Leading companies in the cell processing instruments market are concentrating on developing innovative approaches, such as multi-channel asynchronous processing, to enhance workflow efficiency and flexibility in cell therapy development. Multi-channel asynchronous processing refers to a system’s capability to run several independent workflows simultaneously on separate channels, allowing different processes to operate in parallel without needing to wait for each other to finish. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, launched two new instruments, Python Junior and Matrix NEO, with the goal of improving and standardizing the single-cell analysis workflow. Python Junior streamlines the dissociation of solid tissues into high-quality single-cell suspensions through dual independent channels utilizing a combination of mechanical and enzymatic processing, while Matrix NEO enables high-throughput, fully automated single-cell library preparation, encompassing chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby supporting diverse applications and throughput levels in both research and clinical settings.

    Who Are The Dominant Players Shaping The Cell Processing Instruments Market Landscape?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Read the full cell processing instruments market report here:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    What Are The Top-Performing Regions Within The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Cell Processing Instruments Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Cell Therapy Processing Market Report 2026–2030: Data-Driven Growth Insights

    Global Cell Therapy Processing Market Report 2026–2030: Data-Driven Growth Insights

    Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy processing market from 2026–2035 with trusted insights from The Business Research Company

    How much larger will the Cell Therapy Processing Market be in 2030 compared with 2026?

    The cell therapy processing market has witnessed swift expansion in recent years. It is anticipated to grow from $5.18 billion in 2025 to $5.92 billion in 2026, at a compound annual growth rate (CAGR) of 14.3%. The growth observed in the historic period can be ascribed to increasing clinical trials for cell therapies, expansion of biopharmaceutical manufacturing capacity, availability of specialized processing facilities, growing expertise in gmp compliance, and rising investment in advanced therapeutics.

    The cell therapy processing market is projected for significant expansion over the coming years, reaching $9.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.8%. This anticipated growth during the forecast timeframe stems from several factors, including the increasing commercialization of gene and cell therapies, a rising demand for contract manufacturing services, the expansion of decentralized manufacturing models, the growing adoption of digital quality management systems, and a rise in regulatory approvals for cell-based therapies. Key developments expected during this period involve a greater embrace of GMP-compliant processing platforms, an escalating need for scalable cell therapy manufacturing, the wider integration of workflow automation software, an expansion of contract processing services, and a heightened emphasis on sterility and quality assurance.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    What Drivers Are Guiding Growth Patterns In The Cell Therapy Processing Market?

    An increasing volume of cell therapy research is anticipated to boost the expansion of the cell therapy processing market in the future. Cell therapy involves creating therapeutic products from live cells to manage or treat a range of conditions such as cancers, autoimmune diseases, and genetic ailments. The rising need for scalable and consistent manufacturing platforms, capable of handling high cell densities without impacting product quality, is fueling the demand for cell-based therapies. For cell therapy research, cell therapy processing is advantageous because it facilitates the standardized preparation, quality control, and scalable production of high-quality cells, thus guaranteeing dependable and repeatable results for both experimental and clinical studies. An example of this trend is that in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit body, reported the launch of six first-in-class cell and gene treatments in 2023. This figure represents a 50% increase compared to the three such treatments released in 2022. Consequently, the increasing volume of cell therapy research activities is a primary factor driving the growth of the cell therapy processing market.

    How Is The Cell Therapy Processing Market Divided Into Segments?

    The cell therapy processing market covered in this report is segmented –

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Which Market Trends Are Opening Growth Opportunities In The Cell Therapy Processing Market?

    Leading companies in the cell therapy processing market are prioritizing the creation of advanced solutions, including integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system is a unified device that combines cell incubation and centrifugal separation within a single enclosed unit, facilitating continuous, automated cell processing without the necessity for intermediate transfers. For example, in March 2025, Limula SA, a Switzerland-based company specializing in cell and gene therapy (CGT), introduced LimONE, an automated, closed-system platform for cell therapy manufacturing. This innovative system integrates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing stages, such as incubation, centrifugation, and reagent handling, into a singular compact unit, thereby permitting consistent, scalable production of therapies like CAR-T and gene-edited stem cells from initial research to GMP-compliant manufacturing, bypassing the need for intricate technology transfers.

    Which Key Players Are Driving Competition In The Cell Therapy Processing Market?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Is Projected To Lead The Cell Therapy Processing Market During The Forecast Period?

    North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Cell Therapy Processing Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2026, By The Business Research Company

    Exterior Insulation And Finish System Market Report 2026

    https://www.thebusinessresearchcompany.com/report/exterior-insulation-and-finish-system-global-market-report

    Metal Structural Insulation Panels Market Report 2026

    https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

    Vacuum Insulation Panel Market Report 2026

    https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Instruments Industry Growth Insights: Revenue Forecast to 2030

    Cell Processing Instruments Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the wearable ultrasound patches market from 2026–2035 with trusted insights from The Business Research Company

    What long-term size projections exist for the Cell Processing Instruments Market covering 2026–2035?

    The cell processing instruments market has expanded significantly in recent years. It is projected to increase from $6.95 billion in 2025 to $7.51 billion in 2026, at a compound annual growth rate (CAGR) of 8.1%. The historical expansion of this market can be attributed to several factors: limited automation in cell processing, a reliance on manual cell counting and separation, a rise in academic and research activities, an increasing demand for accurate cell analysis, and the emergence of flow cytometry technologies.

    The market for cell processing instruments is projected to experience robust expansion in the upcoming years. This market is anticipated to reach a valuation of $10.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This projected growth is driven by factors such as the creation of integrated cell processing solutions, a surge in funding for cell therapy and regenerative medicine, the widespread use of digital and automated imaging technologies, an increase in contract research and manufacturing operations, and improvements in live cell analysis and high-content screening techniques. Key developments expected during this period involve a growing need for automated cell processing equipment, greater utilization of flow cytometry and high-content imaging, an expansion in the applications of cell therapy and regenerative medicine, a focus on achieving standardization and adhering to regulatory requirements, and the incorporation of multi-functional cell analysis platforms.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Drivers Are Impacting The Competitive Landscape Of The Cell Processing Instruments Market?

    Future expansion of the cell processing instruments market is anticipated, driven by escalating investments in biopharmaceutical research. Biopharmaceutical research involves the scientific investigation and creation of therapeutic solutions originating from biological elements or mimicking biological structures, aimed at diagnosing, preventing, or managing illnesses. This rise in biopharmaceutical research funding stems from an escalating need for novel treatments for increasing chronic conditions and unaddressed medical requirements, thereby stimulating more intensive research and development initiatives for precise and potent therapies. Cell processing instruments facilitate biopharmaceutical research by providing efficient, standardized, and scalable methods for handling cells, thereby expediting the creation and manufacturing of advanced cell-derived therapies. As an illustration, the BioIndustry Association (BIA), a UK-based trade association, reported in January 2025 that the UK biotech sector saw significant growth in 2024, attracting £3.5 billion (roughly $ 4.4 billion) in investment, marking a notable 94% rise compared to the prior year. Consequently, the expanding investments in biopharmaceutical research are fueling the expansion of the cell processing instruments market.

    What Segments Are Identified Within The Structure Of The Cell Processing Instruments Market?

    The cell processing instruments market covered in this report is segmented –

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Trends Are Expected To Influence The Cell Processing Instruments Market In The Upcoming Years?

    Major companies operating in the cell processing instruments market are emphasizing the creation of innovative methodologies, such as multi-channel asynchronous processing, to enhance workflow efficiency and flexibility in cell therapy development. This multi-channel asynchronous processing denotes a system’s capability to execute multiple independent workflows simultaneously across separate channels, allowing different processes to operate in parallel without requiring each other to finish. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, unveiled two new instruments, Python Junior and Matrix NEO, designed to improve and standardize the single-cell analysis workflow. Python Junior efficiently dissociates solid tissues into high-quality single-cell suspensions utilizing dual independent channels and a combination of mechanical and enzymatic processing, while Matrix NEO enables high-throughput, fully automated single-cell library preparation, including chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, supporting diverse applications and throughput levels in both research and clinical environments.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Regions Are Poised For Strategic Growth In The Cell Processing Instruments Market?

    North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Cell Processing Instruments Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2026, By The Business Research Company

    Cell Free Dna Isolation And Extraction Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

    Dna Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

    Dna Testing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • How Will The Cell Therapy Processing Market Reach $8.73 Billion By 2029 Amid Global Shifts?

    How Will The Cell Therapy Processing Market Reach $8.73 Billion By 2029 Amid Global Shifts?

    Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy processing market from 2025–2034 with trusted insights from The Business Research Company

    What Is The Predicted Market Size Of The Cell Therapy Processing Industry By 2029?

    The cell therapy processing market has seen significant expansion in recent years. It is projected to grow from $4.54 billion in 2024 to $5.18 billion in 2025, with a compound annual growth rate (CAGR) of 14.3%. This historical growth can be attributed to factors such as the increasing adoption of cell-based therapies, rising investment in biomanufacturing infrastructure, growing demand for personalized medicine, enhanced clinical success of cell therapies, and the escalating requirement for good manufacturing practices (GMP)-compliant processing systems.

    The cell therapy processing market is poised for significant expansion in the coming years, with its value projected to reach $8.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. This anticipated growth is driven by several factors, including a heightened emphasis on automated cell processing technologies, the growing incorporation of artificial intelligence (AI) into cell manufacturing workflows, an increasing need for scalable allogeneic cell therapies, greater regulatory encouragement for advanced therapy production, and a surge in collaborations between biotechnology companies and contract development and manufacturing organization (CDMOs). Key trends expected during this period involve progress in closed-system bioreactor technologies, the creation of real-time monitoring tools for cell cultures, novel approaches in cryopreservation and cell storage methods, improvements in cell separation and purification techniques, and the establishment of modular and scalable good manufacturing practices (GMP) manufacturing platforms.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    Which Industry Forces Are Driving The Cell Therapy Processing Market Forward?

    The increasing volume of cell therapy research is projected to stimulate the expansion of the cell therapy processing market moving forward. Cell therapy describes the procedure of producing therapeutic items derived from living cells to treat or manage a range of diseases, including cancers, autoimmune conditions, and genetic ailments. The need for cell-based therapy is escalating due to a rising requirement for scalable and consistent manufacturing platforms that can accommodate high cell densities without compromising the quality of the product. Cell therapy processing proves beneficial for cell therapy research because it enables the standardized preparation, quality control, and scalable production of premium cells, thus ensuring reliable and reproducible outcomes for both experimental and clinical studies. For example, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit body, indicated that six first-in-class cell and gene treatments were rolled out in 2023, which is 50% more than the three introduced in 2022. Therefore, the growing number of cell therapy research activities is a key factor driving the growth of the cell therapy processing market.

    What Is The Segment Breakdown Of The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    How Are Global Trends Impacting The Development Of The Cell Therapy Processing Market?

    Major entities active in the cell therapy processing market are prioritizing the creation of sophisticated solutions, including integrated bioreactor-centrifuge systems, to enhance manufacturing workflows and boost the uniformity, expandability, and sterility of cell-based treatments. An integrated bioreactor-centrifuge system functions as a consolidated apparatus that merges cell incubation and centrifugal separation within a solitary, sealed unit, allowing for continuous, automated cell processing devoid of intermediate transfers. Illustratively, in March 2025, Limula SA, a Switzerland-based company known for cell and gene therapy (CGT) production, unveiled LimONE, an automated, closed-system platform dedicated to cell therapy manufacturing. The innovative system integrates hardware, single-use consumables, and software guided by protocols to consolidate intricate cell processing stages, such as incubation, centrifugation, and reagent handling, into a single compact unit. This facilitates the consistent, scalable production of therapies like CAR-T and gene-edited stem cells, from research phases to GMP-compliant manufacturing, eliminating the necessity for complex technology transfers.

    Which Companies Are Contributing Significantly To The Cell Therapy Processing Market Growth?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Nkarta Inc., Cellares Corporation, Cellectis S.A., JW (Cayman) Therapeutics Company Limited, Cell Therapies Pty Ltd., and InGeneron Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    Which Region Is Leading Innovation In The Cell Therapy Processing Market?

    North America was the largest region in the cell therapy processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2025, By The Business Research Company

    Metal Structural Insulation Panels Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

    Structural Insulated Panels Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

    Vacuum Insulation Panel Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Emerging Trends Are Driving The Cell Processing Instruments Market Toward $9.39 Billion By 2029?

    Which Emerging Trends Are Driving The Cell Processing Instruments Market Toward $9.39 Billion By 2029?

    Uncover key drivers, emerging technologies, and competitive movements shaping the cell processing instruments market from 2025–2034 with trusted insights from The Business Research Company

    What Are The Market Size Estimates For The Cell Processing Instruments Market?

    The cell processing instruments market has experienced substantial growth recently. It is projected to expand from $6.43 billion in 2024 to $6.95 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.2%. This historical expansion can be attributed to several factors, including the increasing need for consistent cell processing protocols, a rising emphasis on personalized medicine, more regulatory approvals for cell therapy products, an uptick in clinical trials utilizing cell-based treatments, and the developing infrastructure of biobanks and cell repositories.

    The cell processing instruments market size is anticipated to experience substantial expansion in the coming years. It is projected to reach $9.39 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is primarily driven by the increasing integration of automation in cell therapy manufacturing, a rising focus on scalable cell processing solutions, an increase in clinical trials for gene and cell therapies, greater investments in advanced bioprocessing technologies, and a growing demand for good manufacturing practice (GMP)-compliant instrumentation. Significant trends expected in the forecast period include advancements in closed-system automation, the development of artificial intelligence (AI)-driven cell analysis tools, innovations in microfluidic cell sorting, progress in integrated quality control (QC) instrumentation, and the establishment of modular bioprocessing platforms.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    Which Growth Drivers Are Shaping The Cell Processing Instruments Market Outlook?

    The rising investment in biopharmaceutical research is projected to propel the expansion of the cell processing instruments market going forward. Biopharmaceutical research entails the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for the purpose of diagnosing, preventing, or treating diseases. The increasing financial commitment to biopharmaceutical research is driven by a growing demand for innovative therapies to address the rise in chronic diseases and unmet medical needs, thus stimulating greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which expedites the development and production of advanced cell-based therapies. For example, in December 2024, data from the International Federation of Pharmaceutical Manufacturers and Associations, a non-profit organization based in Switzerland, showed that 50 pharmaceutical companies invested $167 billion in research and development in 2022. Therefore, the increasing investment in biopharmaceutical research is fueling the growth of the cell processing instruments market.

    What Are The Primary Segmentation Parameters In The Cell Processing Instruments Market?

    The cell processing instruments market covered in this report is segmented

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    Which Emerging Trends Are Reshaping The Cell Processing Instruments Market Landscape?

    Companies active in the cell processing instruments market are prioritizing the development of novel approaches, such as multi-channel asynchronous processing, to boost workflow efficiency and adaptability in cell therapy development. Multi-channel asynchronous processing describes a system’s capacity to execute several distinct workflows concurrently on separate channels, thereby enabling parallel operation without mutual completion dependencies. For instance, in June 2023, Singleron Biotechnologies GmbH, a biotechnology firm based in Germany, unveiled two new instruments, Python Junior and Matrix NEO, aimed at refining and standardizing the single-cell analysis workflow. Python Junior efficiently dissociates solid tissues into superior quality single-cell suspensions, leveraging dual independent channels with both mechanical and enzymatic processing. Meanwhile, Matrix NEO facilitates high-throughput, entirely automated single-cell library preparation, incorporating chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby accommodating various applications and throughput requirements in both research and clinical environments.

    Which Organizations Are At The Forefront Of The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., and InGeneron Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Region Holds The Greatest Opportunity For Cell Processing Instruments Market Expansion?

    North America was the largest region in the cell processing instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2025, By The Business Research Company

    Quick Response Qr Codes Payment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/quick-response-qr-codes-payment-global-market-report

    Pay Per Click Ppc Software Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/pay-per-click-ppc-software-global-market-report

    Gifts Retailing Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gifts-retailing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Therapy Processing Market Size Forecast: Revenue and CAGR by 2029

    Cell Therapy Processing Market Size Forecast: Revenue and CAGR by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Global Market Value Of The Cell Therapy Processing Industry In 2025?

    The cell therapy processing market size has shown rapid expansion in recent years. It is projected to grow from $4.54 billion in 2024 to $5.18 billion in 2025, at a compound annual growth rate (CAGR) of 14.3%. The market’s growth in the preceding period can be linked to the increased adoption of cell-based therapies, rising investment in biomanufacturing infrastructure, a surge in demand for personalized medicine, the growing clinical success of cell therapies, and the escalating need for good manufacturing practices (GMP)-compliant processing systems.

    The cell therapy processing market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $8.73 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.9%. This expansion during the projection period stems from a heightened emphasis on automated cell processing technologies, the growing incorporation of artificial intelligence (AI) into cell manufacturing processes, an escalating need for scalable allogeneic cell therapies, increased regulatory assistance for advanced therapy production, and a rise in collaborations between biotechnology companies and contract development and manufacturing organization (CDMOs). Key developments anticipated within this timeframe encompass improvements in closed-system bioreactor technologies, the creation of real-time monitoring instruments for cell cultures, breakthroughs in cryopreservation and cell storage techniques, advancements in cell separation and purification methods, and the establishment of modular and scalable good manufacturing practices (GMP) manufacturing platforms.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27244&type=smp

    What Are The Top Growth Drivers Impacting The Cell Therapy Processing Market Outlook?

    The increasing volume of cell therapy research endeavors is projected to drive the expansion of the cell therapy processing market. Cell therapy involves creating therapeutic products derived from living cells to treat or manage a range of conditions, including cancers, autoimmune disorders, and genetic diseases. The rising demand for cell-based therapy stems from the critical need for scalable and consistent manufacturing platforms that can support high cell densities without sacrificing product quality. Cell therapy processing provides advantages for cell therapy research by enabling standardized preparation, stringent quality control, and scalable production of high-quality cells, thus ensuring reliable and reproducible outcomes for both experimental and clinical investigations. As an illustration, in December 2024, the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, stated that six first-in-class cell and gene treatments were launched in 2023, which signifies a 50% increase compared to the three introduced in 2022. Consequently, the expanding number of cell therapy research activities is propelling the growth of the cell therapy processing market.

    What Are The Key Segments In The Cell Therapy Processing Market?

    The cell therapy processing market covered in this report is segmented

    1) By Offering Type: Products, Services, Software

    2) By Applications: Cardiovascular Devices, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications

    3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents

    2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services

    3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

    Which Ongoing Trends Are Expected To Shape The Cell Therapy Processing Market Outlook?

    Leading companies active in the cell therapy processing market are concentrating on developing advanced solutions, such as integrated bioreactor-centrifuge systems, to optimize manufacturing workflows and enhance the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system is a combined device that incorporates cell incubation and centrifugal separation within a single sealed unit, facilitating continuous, automated cell processing without requiring intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based company manufacturing cell and gene therapy (CGT), launched LimONE, an automated, closed-system platform for cell therapy manufacturing. This innovative system merges hardware, single-use consumables, and protocol-driven software to simplify complex cell processing stages like incubation, centrifugation, and reagent handling into one compact unit, enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from research through to GMP-compliant manufacturing, without the need for intricate technology transfers.

    Who Are The Core Companies Influencing The Cell Therapy Processing Market Landscape?

    Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Nkarta Inc., Cellares Corporation, Cellectis S.A., JW (Cayman) Therapeutics Company Limited, Cell Therapies Pty Ltd., and InGeneron Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/cell-therapy-processing-global-market-report

    How Is Cell Therapy Processing Market Demand Varying Across Different Regions?

    North America was the largest region in the cell therapy processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Cell Therapy Processing Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=27244&type=smp

    Browse Through More Reports Similar to the Global Cell Therapy Processing Market 2025, By The Business Research Company

    Metal Structural Insulation Panels Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

    Sandwich Panels Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

    Structural Insulated Panels Market 2025

    https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Cell Processing Instruments Market Forecast: What to Expect by 2029

    Cell Processing Instruments Market Forecast: What to Expect by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Is The Projected Market Size Of The Cell Processing Instruments Market By 2029?

    The cell processing instruments market size has shown strong growth over recent years. It is anticipated to expand from $6.43 billion in 2024 to $6.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion can be ascribed to the increasing need for consistent cell processing protocols, an elevated focus on personalized medicine, a rise in regulatory approvals for cell therapy products, an increase in clinical trials involving cell-based treatments, and the expanding infrastructure of biobanks and cell repositories.

    The cell processing instruments market size is anticipated to show robust expansion in the coming years, with projections indicating it will reach $9.39 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.8%. This growth throughout the forecast period is primarily driven by factors such as the increasing incorporation of automation in cell therapy manufacturing, a heightened focus on scalable cell processing solutions, an increase in clinical trials for gene and cell therapies, greater investments in advanced bioprocessing technologies, and a growing requirement for good manufacturing practice (GMP)-compliant instrumentation. Significant trends expected during this period include improvements in closed-system automation, the emergence of artificial intelligence (AI)-driven cell analysis tools, innovations in microfluidic cell sorting, progress in integrated quality control (QC) instrumentation, and the creation of modular bioprocessing platforms.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=27242&type=smp

    What Are The Main Drivers Boosting The Cell Processing Instruments Industry’s Expansion?

    A surge in financial commitment towards biopharmaceutical research is anticipated to drive the expansion of the cell processing instruments market in the future. Biopharmaceutical research encompasses the scientific investigation and creation of therapeutic products originating from biological sources or engineered to emulate biological molecules, used for the diagnosis, prevention, or treatment of illnesses. This heightened investment is driven by an escalating demand for innovative therapies to tackle the growing prevalence of chronic diseases and address unfulfilled medical requirements, thereby encouraging more extensive research and development endeavors for targeted and effective treatments. Cell processing instruments play a crucial role in supporting biopharmaceutical research by allowing for efficient, standardized, and scalable handling of cells, which in turn speeds up the advancement and manufacture of sophisticated cell-based therapies. For instance, in December 2024, data provided by the International Federation of Pharmaceutical Manufacturers and Associations, a non-profit organization based in Switzerland, revealed that 50 pharmaceutical companies collectively invested $167 billion in research and development during 2022. Consequently, the expanding financial commitment to biopharmaceutical research is a key factor propelling the growth of the cell processing instruments market.

    What Are The Segment Types Shaping The Cell Processing Instruments Market?

    The cell processing instruments market covered in this report is segmented

    1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments

    2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications

    3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses

    Subsegments:

    1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters

    2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems

    3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers

    4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems

    5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms

    6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

    What Are The Latest Industry Trends Transforming The Cell Processing Instruments Market?

    Leading companies in the cell processing instruments market are concentrating on creating novel strategies, such as multi-channel asynchronous processing, to improve the efficiency and adaptability of workflows in cell therapy development. This multi-channel asynchronous processing describes a system’s capability to execute several independent workflows simultaneously on distinct channels, allowing different processes to run in parallel without requiring one another to finish. An illustrative example occurred in June 2023 when Singleron Biotechnologies GmbH, a German biotechnology firm, introduced two new instruments, Python Junior and Matrix NEO, aimed at enhancing and standardizing the single-cell analysis workflow. Python Junior facilitates the dissociation of solid tissues into high-quality single-cell suspensions by utilizing dual independent channels and a combination of mechanical and enzymatic processing. Concurrently, Matrix NEO enables comprehensive, automated single-cell library preparation, encompassing chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, thereby supporting various applications and throughput requirements in both research and clinical environments.

    Who Are The Prominent Global Companies Shaping The Cell Processing Instruments Market?

    Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., and InGeneron Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/cell-processing-instruments-global-market-report

    Which Region Is Projected To Lead The Cell Processing Instruments Market During The Forecast Period?

    North America was the largest region in the cell processing instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Cell Processing Instruments Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=27242&type=smp

    Browse Through More Reports Similar to the Global Cell Processing Instruments Market 2025, By The Business Research Company

    Quick Response Qr Codes Payment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/quick-response-qr-codes-payment-global-market-report

    Digital Gift Card Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/digital-gift-card-global-market-report

    Pay Per Click Ppc Software Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/pay-per-click-ppc-software-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model